Summary
ABH Healthcare IPO is a ₹34.98 crore fresh issue, priced at ₹96 to ₹102 per share, with bidding open from 24 August to 27 August 2026.
The issue offers up to 34,29,600 equity shares and has a lot size of 1,200 shares. The company has opted not to have anchor investor participation.
ABH Healthcare reported consolidated revenue from operations of ₹5,250.69 lakh and profit after tax of ₹563.94 lakh in FY2026.
For FY2026, ROE stood at 39.07%, ROCE at 19.09% and the debt-to-equity ratio at 3.20.
ABH Healthcare is coming to the SME market with a book-built IPO of up to 34,29,600 fresh equity shares. The shares carry a face value of ₹10 and the price band has been fixed at ₹96 to ₹102.
The issue will accept bids from 24 to 27 August 2026. Allotment is scheduled for 28 August, followed by the NSE Emerge listing on 1 September. Investors can bid in lots of 1,200 shares.
ABH Healthcare IPO Details
The table below shows the key details of the ABH Healthcare IPO.
| Particulars | Details |
| IPO Open Date | 24 August 2026 |
| Close Date | 27 August 2026 |
| Face value | ₹10 per equity share |
| Price Band | ₹96 to ₹102 per share |
| Issue Price | To be finalised |
| IPO Lot Size | 1,200 equity shares |
| Offer for sale | Nil |
| Fresh issue | Up to 34,29,600 equity shares |
| Issue Type | 100% Book Built SME IPO |
| Listing at | NSE Emerge |
| Total Issue Size | Up to ₹3,498.19 lakh at the cap price |
| Minimum Investment | See IPO lot size section |
ABH Healthcare IPO Timeline
The table below shows the ABH Healthcare IPO timeline.
| Event | Date |
| IPO Open Date | 24 August 2026 |
| IPO Close Date | 27 August 2026 |
| Tentative Allotment | 28 August 2026 |
| Initiation of Refunds | 31 August 2026 |
| Credit of Shares to Demat | 31 August 2026 |
| Tentative Listing Date | 1 September 2026 |
| Cut-off time for UPI mandate confirmation | 5:00 PM on 27 August 2026 |
ABH Healthcare Key Performance Indicator
The latest KPIs for ABH Healthcare are:
| Key Performance Indicator | FY2024 | FY2025 | FY2026 |
| ROE | 30.33% | 59.75% | 39.07% |
| ROCE | 14.96% | 22.70% | 19.09% |
| Debt-to-Equity Ratio | 5.69 | 3.62 | 3.20 |
| RoNW | 30.33% | 59.75% | 39.07% |
| PAT Margin | 4.00% | 10.85% | 10.74% |
| EBITDA Margin | 16.66% | 26.78% | 28.03% |
| Price-to-Book Value | – | – | – |
ABH Healthcare IPO Financials
The table below shows ABH Healthcare’s consolidated financials for FY2024 to FY2026.
| ₹ in lakh | FY2024 | FY2025 | FY2026 |
| Revenue from Operations | 4,138.02 | 4,926.71 | 5,250.69 |
| Total Assets | 5,134.58 | 6,390.40 | 8,527.32 |
| Profit After Tax | 165.56 | 534.70 | 563.94 |
ABH Healthcare IPO Subscription Status
| Date | QIB (Ex Anchor) | NII* | Individual Investors | Total |
|---|---|---|---|---|
| Aug 24 (Day 1) | 3.45 | 0.14 | 0.20 | 0.30 |
ABH Healthcare IPO Grey Market Premium (GMP Today)
The table below shows the latest ABH Healthcare IPO GMP.
| GMP Date | GMP | Est. Listing Price (cap price + GMP) | Est. Profit* | Last Updated |
|---|---|---|---|---|
| 24-08-2026 Open | ₹0 ─ | ₹102 (0.00%) | ₹0 | 24-Aug-2026 12:56 |
| 23-08-2026 | ₹0 ─ | ₹102 (0.00%) | ₹0 | 23-Aug-2026 23:29 |
| 22-08-2026 | ₹0 ─ | ₹102 (0.00%) | ₹0 | 22-Aug-2026 23:30 |
| 21-08-2026 | ₹0 ─ | ₹102 (0.00%) | ₹0 | 21-Aug-2026 23:30 |
| 20-08-2026 | ₹0 ─ | ₹102 (0.00%) | ₹0 | 20-Aug-2026 23:29 |
| 19-08-2026 | ₹0 ─ | ₹102 (0.00%) | ₹0 | 19-Aug-2026 23:28 |
| 18-08-2026 | ₹0 ─ | ₹102 (0.00%) | ₹0 | 18-Aug-2026 23:33 |
| 17-08-2026 | ₹0 ─ | ₹102 (0.00%) | ₹0 | 17-Aug-2026 23:29 |
ABH Healthcare IPO GMP is ₹0 as of 20 August 2026. Grey-market activity has not started, so no premium is indicated at present.
Note: GMP values come from the grey market and can change quickly with demand, subscription levels and broader market sentiment.
ABH Healthcare IPO Reservation
The table below shows the ABH Healthcare IPO reservation across investor categories.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue |
| Market Maker | 1,72,800 | – | 5.04% |
| QIB | 1,99,200 | 6.12% | 5.81% |
| NII (HNI) | 15,28,800 | 46.94% | 44.58% |
| Individual Investors | 15,28,800 | 46.94% | 44.58% |
| Total Shares Offered | 34,29,600 | 100.00% | 100.00% |
ABH Healthcare IPO Lot Size
The table below shows the application size for each investor category.
| Application Category | Lots | Shares | Amount |
| Individual Investors (Min) | 2 | 2,400 | ₹2,44,800 |
| Individual Investors (Max) | 2 | 2,400 | ₹2,44,800 |
| S-HNI (Min) | 3 | 3,600 | ₹3,67,200 |
| S-HNI (Max) | 8 | 9,600 | ₹9,79,200 |
| B-HNI (Min) | 9 | 10,800 | ₹11,01,600 |
ABH Healthcare IPO Anchor Investors
ABH Healthcare IPO does not have an anchor investor allocation. No anchor investor participation is being considered for the issue.
ABH Healthcare IPO Prospectus
The following offer documents are available for the ABH Healthcare IPO:
About ABH Healthcare
ABH Healthcare Limited was incorporated in March 2021. The company acquired the business of Anil Baghi Hospital in 2022, while the hospital itself was founded by Dr Kamal Baghi in 1985.
ABH Healthcare operates Anil Baghi Hospital in Ferozepur, Punjab. It has 150 beds and provides treatment across 25 medical specialities.
Its services include cardiac sciences, neurology, gastroenterology, urology, pulmonology, nephrology, ENT and orthopaedics. The hospital also provides critical care, bariatric surgery, radiology, physiotherapy and other medical services.
The table below lists the key intermediaries for the IPO.
| Particulars | Name |
| Book Running Lead Manager | Fedex Securities Private Limited |
| Registrar of the Issue | Bigshare Services Private Limited |
Objectives of the ABH Healthcare IPO
ABH Healthcare plans to use the net proceeds for the following purposes:
| Purpose | Amount / Description |
| Repayment or prepayment of certain borrowings | ₹1,700 lakh |
| Working capital requirements | ₹500 lakh |
| General corporate purposes (including unidentified acquisitions) | Amount to be finalised after the issue price is determined |
Strengths of ABH Healthcare
- Doctor-led management: Dr Kamal Baghi has around four decades of healthcare experience. Dr Saurabh Baghi, the Managing Director, has around 10 years of experience in the sector.
- Range of clinical services: The hospital offers 25 medical specialities, covering several areas of tertiary and critical care.
- Clinical team: The business focuses on attracting and retaining doctors and other healthcare professionals across its specialities.
- Hospital infrastructure: Operations are supported by medical equipment, information technology systems and a 150-bed facility.
- Operating track record: The hospital has an established operating history, while the current company took over the business in 2022.
Risks of ABH Healthcare
- Single-hospital dependence: The company derives almost all its operating revenue from its hospital in Ferozepur. A disruption at this location could affect the wider business.
- High leverage: The company has a debt-equity ratio of 3.20. Higher borrowings or weaker cash generation could affect its ability to service debt.
- Limited operating history as a company: ABH Healthcare was incorporated before acquiring the existing hospital business in 2022, making its corporate operating history relatively short.
- Reliance on key people: Operations depend on the promoters, senior management, doctors and other healthcare professionals.
- Premises are not owned: The company does not own the property where its registered office and hospital operate.
- Acquisition risk: Part of the issue proceeds may be used for acquisitions that have not yet been identified.
- Regulatory exposure: Healthcare businesses must comply with multiple safety, health and other regulatory requirements.
ABH Healthcare IPO Review
ABH Healthcare operates a 150-bed hospital with 25 medical specialities in Ferozepur. Revenue from operations increased from ₹4,138.02 lakh in FY2024 to ₹5,250.69 lakh in FY2026. PAT moved from ₹165.56 lakh to ₹563.94 lakh over the same period.
There are risks to consider. The business depends heavily on a single hospital, its hospital premises are not owned and the debt-equity ratio stood at 3.20 in FY2026. Dependence on promoters and medical professionals is another factor.
The issue therefore needs to be viewed in the context of both its recent financial performance and its concentration and borrowing risks. Investors can also assess the final valuation before deciding whether the IPO fits their risk profile.
Other Recent IPO List
The table below lists some current and upcoming IPOs around the Hy-Tech Engineers IPO period.
ABH Healthcare IPO FAQs
ABH Healthcare IPO is an SME book-built issue with a price band of ₹96 to ₹102 per share. It will list on NSE Emerge.
You can apply through the IPO section of your broker or through your bank’s ASBA facility. Select ABH Healthcare, enter the required bid quantity and complete the UPI mandate where applicable.
ABH Healthcare has reported higher revenue and PAT in recent years. However, it depends heavily on one hospital and has a debt-equity ratio of 3.20, so these risks should be considered along with the valuation.
ABH Healthcare IPO GMP is ₹0 as of 20 August 2026, with an estimated listing price of ₹102. GMP is unofficial and actual listing returns may differ.
ABH Healthcare IPO opens on 24 August 2026 and closes on 27 August 2026.
The lot size is 1,200 shares. Individual investors need to apply for a minimum of two lots, or 2,400 shares, amounting to ₹2,44,800.
You can place an application through a broker offering IPO applications or through ASBA in net banking. Make sure the bid quantity follows the applicable lot requirement.
The tentative allotment date is 28 August 2026.
ABH Healthcare shares are tentatively scheduled to list on NSE Emerge on 1 September 2026.
